Daptomycin Treatment Failure for Vancomycin-Resistant Enterococcus faecium Infective Endocarditis: Impact of Protein Binding?

Abstract

Get full access to this article

View all access options for this article.

References

Carpenter

, Chambers

. Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens. Clin Infect Dis2004;38:994–1000.

Segreti

, Crank

, Finney

. Daptomycin for the treatment of gram-positive bacteremia and infective endocarditis: a retrospective case series of 31 patients. Pharmacotherapy2006;26:347–52.

Lee

, Sachdeva

, Chambers

. Effect of protein binding of daptomycin on MIC and antibacterial activity. Antimicrob Agents Chemother1991;35:2505–8.

Package insert. Cubicin (daptomycin). Lexington, MA: Cubist Pharmaceuticals, 2007.

Safdar

, Andes

, Craig

. In vivo pharmacodynamic activity of daptomycin. Antimicrob Agents Chemother2004;48:63–8.

Michiels

, Bergeron

. Differential increased survival of staphylococci and limited ultrastructural changes in the core of infected fibrin clots after daptomycin administration. Antimicrob Agents Chemother1996;40:203–11.